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ABSTRACT
Objectives To explore whether advance care
planning is associated with place of death in
England, as well as with sufficiency of support to
care for a dying person at home, overall quality
of care and pain management.
Methods We undertook secondary analysis of
data from the National Survey of Bereaved
People, 2013, based on a stratified random
sample of 49 607 people selected from 150 111
eligible registered deaths (n=22 661, 46%
response rate). The indicator of advance care
planning used was having expressed a
preference for place of death and this being
recorded by healthcare staff. Analysis was
conducted using logistic regression models.
Results Decedents with a recorded preference
for place of death had significantly greater odds
of dying at home rather than in hospital (OR
6.25; 99% CI 5.56 to 7.14) and in a care home
rather than in hospital (OR 2.70; 99% CI 2.33 to
3.13). They also had significantly greater odds of
receiving sufficient support to be cared for and
to die at home, of receiving ‘outstanding’ or
‘excellent’ care, and of having pain relieved
‘completely, all the time’ while being cared for at
home.
Conclusions Advance care planning was found
to be strongly associated with lower rates of
hospital death and a range of quality outcomes.
These findings provide support for the emphasis
on advance care planning in end of life care
policy in England, while also suggesting the need
for further research to better understand the
mechanisms underlying these relationships.
INTRODUCTION
Most people prefer to die in their usual
place of residence (own home or care
home) if provided with the right
support.1 2 In England, the proportion of
deaths in usual place of residence is a key
quality indicator for end of life care,3 and
has increased from 38% in 2008 to 45%
in 2015.4
Advance care planning is a voluntary
process of discussion and review concern-
ing future care and treatment. It is con-
sidered a means for helping people die in
their preferred place and is emphasised in
the end of life care strategy for England.5
In England, advance statements set out
general preferences to inform
best-interest decisions, while advance
decisions to refuse treatment are legally
binding and regulated by the Mental
Capacity Act (2005). In the USA, the
Patient Self-Determination Act (PSDA,
1990) requires Medicare-registered and
Medicaid-registered healthcare agencies
to provide information about advance
directives (advance decisions) and incorp-
orate them into medical records.
We undertook secondary analyses of
data from the National Survey of
Bereaved People, 2013, to explore
whether, in England, advance care plan-
ning, indicated by an expressed prefer-
ence for place of death that is recorded
by healthcare staff, is associated with
where people die.6 We also explored a
range of secondary outcomes; sufficient
support to care for a dying person at
home, overall quality of care and effect-
iveness of pain management.
METHODS
Study population and data sources
The National Survey of Bereaved People,
first conducted in 2011, is commissioned
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by National Health Service (NHS) England and admi-
nistered by the Office for National Statistics (ONS).
For the 2013 release, a stratified random probability
sample of 49 607 people was selected from 150 111
people registering a death between 1 January 2013
and 30 April 2013.6 Stratification was according to
cause of death, place of death and geographic spread
(NHS Area Team). Respondents, usually family
members, were surveyed between 4 and 11 months
after the registered death. Responses were received
from 22 661 individuals (response rate, 45.7%).
Non-response was associated with the decedent being
male, younger, dying at home or in hospital (rather
than care home or hospice), being from a black, Asian
or minority ethnic (BAME) group and living in an
area of greater deprivation. Sampling weights were
used to account for bias in the probability of selection
and non-response. Further information on survey
methodology is available from the ONS.7
The advance care planning measure
Previous research has used a range of different
advance care planning indicators, including comple-
tion of advance directives, completion of
treatment-limiting advance directives, the occurrence
of end of life care discussions with family members
and/or healthcare professionals, and, in a recent UK
study,8 having a preference for place of death
recorded in medical records. The current study uses
the indicator of an expressed preference for place of
death that is recorded by healthcare staff. Survey
respondents were asked (Q41) Did s/he ever say
where s/he would like to die? Those answering ‘yes’
(rather than ‘no’ or ‘not sure’) were then asked (Q42)
Where did s/he say that s/he would like to die? and
provided with a list of possible locations. They were
then asked (Q43) Did the healthcare staff have a
record of this? Those considered to have engaged in
advance care planning were those answering ‘yes’ to
Q43. Everyone else was considered, for the purposes
of this research, not to have engaged in advance
care planning.
Primary outcome measures
Place of death: Place of death information was taken
from death certificates, with the response options
used in our analyses being hospital, home and care
home. From these, we constructed two parallel mea-
sures for place of death; dying at home (rather than
hospital) and dying in a care home (rather than
hospital).
Secondary outcome measures
Sufficient support to care for the dying person at
home: The survey asked (Q2) Did s/he [the decedent]
spend any time at home during the last three months
of life? Where the answer was yes, respondents were
asked (Q5) Overall, do you feel that you and your
family got as much help and support from health and
social services as you needed when caring for him/her?
Response categories were:
▸ Yes, we got as much help and support as we wanted;
▸ Yes, we got some support but not as much as we wanted;
▸ No, although we tried to get more support;
▸ No, but we did not ask for more help;
▸ We did not need help.
A binary measure was constructed; ‘yes, we got as
much help and support as we wanted’ compared with
all other responses (except for ‘we did not need help’;
respondents giving this answer were excluded from
analysis).
Overall quality of care: The survey asked (Q51)
Overall, and taking all services into account, how
would you rate his/her [the decedent’s] care in the last
three months of life? The response categories for this
question were:
▸ Outstanding,
▸ Excellent,
▸ Good,
▸ Fair,
▸ Poor,
▸ Don’t know.
The binary measure used in analyses was overall
care that was ‘outstanding’ or ‘excellent’ compared
with all other responses (except for ‘don’t know’,
which were excluded from analysis).
Effectiveness of pain management: The survey asked
(Q6) During the last three months of his/her [the dece-
dent’s] life, while s/he was at home, how well was his/
her pain relieved? For those who spent time in a care
home, it asked (Q22) During the last three months of
his/her life, while s/he was in the care home, how well
was his/her pain relieved? Finally, for those who spent
time in hospital, it asked (Q26) During his/her last
hospital admission, how well was his/her pain
relieved? The response categories for each of these
were:
▸ Does not apply—s/he did not have any pain;
▸ Completely, all of the time;
▸ Completely, some of the time;
▸ Partially;
▸ Not at all;
▸ Don’t know.
The binary outcome measure in each case was pain
relieved ‘completely, all of the time’ compared with
all other responses (except ‘does not apply—s/he did
not have any pain’ and ‘don’t know’, which were
excluded from analysis).
Statistical analysis
Multivariate logistic regression analysis was conducted
for each outcome in turn. Advance care planning was
the outcome measure for one model, designed to
identify the decedent characteristics independently
associated with having a preferred place of death
recorded by healthcare staff. The remaining logistic
Research
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regression models included advance care planning as
an independent variable. Other covariates were:
▸ Age (18–64 years/65–79 years/80+ years);
▸ Sex (male/female);
▸ Cause of death (haematological cancer/non-
haematological cancer/respiratory illness/neurological
conditions including dementia/heart and circulatory/
renal failure/other conditions). These data were taken
from death certificate information;
▸ Area deprivation (Index of Multiple Deprivation (IMD)
quintiles);
▸ Surviving spouse/partner, using proxy of whether survey
respondent identifies themselves as the spouse or partner
of the decedent (yes/ no);
▸ Ethnic background (white/BAME).
Each regression model included only those cases
with complete data on the outcome and independent
variables. The sample size for each model is provided
in tables 2–7. All statistical analyses were conducted
using the STATA statistical package—V.12.1 (STATA,
2011). A significance level of 0.01 was selected
because of the large sample size (increasing the poten-
tial for type 1 errors) and large number of tests
conducted. The fit of each model was assessed using
the proportion of cases for which the model predicted
the same outcome as observed in the data.
RESULTS
The characteristics of the complete sample of dece-
dents (n=22 661) and survey respondents are sum-
marised in table 1. Women comprise the majority of
decedents and survey respondents. People from
BAME groups are under-represented in both groups.
Most respondents (59.8%) are sons or daughters of
the decedent, while a quarter (24.5%) are spouses or
partners.
Characteristics of people with a recorded preference for
place of death
People with non-cancer diagnoses had significantly
lower odds than those with (non-haematological)
cancer of having a recorded preference for place of
Table 2 Logistic regression of factors associated with advance
care planning†; N=21 032
Effect OR 99% CI
Age at death
18–64 0.94 0.79 to 1.12
65–79 1.07 0.95 to 1.21
80 or above 1.00
Sex
Female 1.04 0.94 to 1.16
Male 1.00
Cause of death
Cardiovascular disease 0.16* 0.14 to 0.19
Haematological cancer 0.82 0.63 to 1.07
Neurological condition 0.20* 0.17 to 0.24
Respiratory illness 0.29* 0.24 to 0.35
‘Other’ causes‡ 0.21* 0.18 to 0.25
Non-haematological cancer 1.00
Level of deprivation of area of residence (IMD quintile)
Most deprived 0.73* 0.62 to 0.87
Second most deprived 0.80* 0.68 to 0.94
Third most deprived 0.87 0.74 to 1.01
Fourth most deprived 0.84* 0.72 to 0.98
Least deprived 1.00
Relationship of respondent
Child/friend/other 0.78* 0.69 to 0.89
Spouse or partner 1.00
Ethnicity
Black or Asian minority ethnic 0.64* 0.44 to 0.94
White 1.00
Per cent correctly classified (predicted vs
observed)
69.7%
*p Value <0.01.
†Indicated by having expressed a preference for place of death that was
recorded by healthcare staff.
‡Other than cancer, cardiovascular disease, neurological conditions, renal
failure or respiratory.
IMD, Index of Multiple Deprivation.
Table 1 Demographic data for decedents
Characteristic Number* Percentage
Sex of decedent
Female 12 701 56.0
Male 9960 44.0
Age at death of decedent
18–59 1146 5.1
60–69 2208 9.7
70–79 4363 19.3
80–89 8726 38.5
90 and over 6218 27.4
Ethnic background of decedent
White 20 719 97.6
Mixed 37 0.2
Asian/Asian British 281 1.3
Black/African/Caribbean/black British 144 0.7
Other 38 0.2
Place of death
Home 4523 20.0
Hospital 10 851 47.9
Care home 6013 26.5
Hospice 1274 5.6
Area deprivation of place of residence (IMD 2010)
1 (most deprived) 3488 15.4
2 4310 19.0
3 4947 21.8
4 5038 22.2
5 (least deprived) 4878 21.5
Source: ONS 2014.
*Demographic data for decedents is complete (n=22 661), with missing
data identified from death certificates.
IMD, Index of Multiple Deprivation; ONS, Office for National Statistics.
Research
Dixon J, et al. BMJ Supportive & Palliative Care 2016;0:1–10. doi:10.1136/bmjspcare-2015-000971 3
group.bmj.com on August 2, 2016 - Published by http://spcare.bmj.com/Downloaded from 
death. This includes those with cardiovascular disease,
OR 0.16 (99% CI 0.14 to 0.19); neurological condi-
tions including dementia, OR 0.20 (99% CI 0.17 to
0.24); respiratory illness, OR 0.29 (99% CI 0.24 to
0.35); and ‘other’ conditions, OR 0.21 (99% CI 0.18
to 0.25). Compared with those living in the least
deprived IMD quintile, people in other IMD quintiles
had lower odds of having a recorded preference for
place of death. This includes people in the most
deprived IMD quintile (OR 0.73; 99% CI 0.62 to
0.87), the second most deprived IMD quintile (OR
0.80; 99% CI 0.68 to 0.94) and the second least
deprived IMD quintile (OR 0.84; 99% CI 0.72 to
0.98). The OR for those in the middle IMD quintile
was similar (OR 0.87); however, this did not quite
achieve statistical significance (99% CI 0.74 to 1.01).
People without a spouse or partner also had lower
odds of having a recorded preference for place of
death (OR 0.78; 99% CI 0.69 to 0.89), as did those
from a BAME group, compared with people of white
ethnicity (OR 0.64; 99% CI 0.44 to 0.94). Full results
are given in table 2.
Primary outcome measures: place of death
Dying at home (rather than hospital)
Of our total sample, 20% (n=4523) died at home
and 48% (n=10 851) died in hospital. Of these, 15%
had a preferred place of death recorded by healthcare
Table 4 Logistic regression of factors associated with death in a
care home†; N=16 845
Effect OR 99% CI
Age at death
Ages 18–64 0.46* 0.38 to 0.55
Ages 65–79 0.51* 0.45 to 0.57
80 or above 1.00
Sex
Female 0.66* 0.60 to 0.72
Male 1.00
Cause of death
Cardiovascular disease 0.31* 0.29 to 0.33
Haematological cancer 0.47* 0.34 to 0.65
Neurological condition 1.76* 1.56 to 1.97
Respiratory illness 0.34* 0.30 to 0.39
‘Other’ causes‡ 0.30* 0.27 to 0.33
Non-haematological cancers 1.00
Level of deprivation of area of residence (IMD quintile)
Most deprived 0.61* 0.53 to 0.71
Second most deprived 0.79* 0.69 to 0.91
Third most deprived 0.95 0.83 to 1.09
Fourth most deprived 0.98 0.86 to 1.12
Least deprived 1.00
Relationship of respondent
Child/friend/other 1.43* 1.26 to 1.62
Spouse or partner 1.00
Ethnicity
Black or Asian minority ethnic 0.59* 0.42 to 0.83
White 1.00
Advance care plan§
Yes 2.70* 2.33 to 3.13
No 1.00
Per cent correctly classified
(predicted vs observed)
72.3%
*p Value <0.01.
†Dependent variable ‘place of death’ coded as 0—death in a hospital and
1—death in a care home.
‡Other than cancer, cardiovascular disease, neurological conditions, renal
failure or respiratory illness.
§Indicated by having expressed a preference for place of death that was
recorded by healthcare staff.
IMD, Index of Multiple Deprivation.
Table 3 Logistic regression of factors associated with death at
home†; N=14 242
Effect OR 99% CI
Age at death
18–64 1.46* 1.20 to 1.78
65–79 1.35* 1.19 to 1.54
80 or above 1.00
Sex
Female 0.89* 0.80 to 0.99
Male 1.00
Cause of death
Cardiovascular disease 0.72* 0.66 to 0.78
Haematological cancer 0.45* 0.33 to 0.63
Neurological condition 0.49* 0.40 to 0.59
Respiratory illness 0.38* 0.33 to 0.45
‘Other’ causes‡ 0.32* 0.28 to 0.37
Non-haematological cancers 1.00
Level of deprivation of area of residence (IMD quintile)
Most deprived 0.69* 0.58 to 0.82
Second most deprived 0.83* 0.70 to 0.98
Third most deprived 0.88 0.75 to 1.03
Fourth most deprived 0.88 0.75 to 1.02
Least deprived 1.00
Relationship of respondent
Child/friend/other 0.87* 0.77 to 1.00
Spouse or partner 1.00
Ethnicity
Black or Asian minority ethnic 0.91 0.65 to 1.27
White 1.00
Advance care plan§
Yes 6.25* 5.56 to 7.14
No 1.00
Per cent correctly classified
(predicted vs observed)
73.6%
*p Value <0.01.
†Dependent variable ‘place of death’ coded as 0—death in a hospital and
1—death at home.
‡Other than cancer, cardiovascular disease, neurological conditions, renal
failure or respiratory illness.
§Indicated by having expressed a preference for place of death that was
recorded by healthcare staff.
IMD, Index of Multiple Deprivation.
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staff. Those with a recorded preference had signifi-
cantly greater odds of dying at home rather than in
hospital (OR 6.25; 99% CI 5.56 to 7.14). This factor
had the largest effect. Other significant factors were
being younger than 80, being male, having (non-
haematological) cancer, living in the least deprived
areas and having a spouse or partner. Full results are
given in table 3.
Dying in a care home (rather than hospital)
Thirty-two per cent of people in our sample
(n=7287) died in a care home. Of people who died
in a care home or in hospital, 10% had a preferred
place of death recorded by healthcare staff. These
individuals had significantly greater odds of dying in a
care home rather than hospital (OR 2.70; 99% CI
2.33 to 3.13). Other significant factors were being
aged 80 or over, being male, having a neurological
condition (including dementia), living in the least
deprived areas, being of white ethnicity and not
having a spouse or partner. Full results are presented
in table 4.
Secondary outcomes
Having sufficient support to care for a dying person at home
Fifty-five per cent of respondents (n=12 348) said
they needed help to look after the decedent at home.
Table 6 Logistic regression of factors associated with ‘excellent’
or ‘outstanding’ overall quality of care†; N=19 850
Effect OR 99% CI
Age at death
18–64 0.88 0.75 to 1.02
65–79 0.85* 0.77 to 0.95
80 or above 1.00
Sex
Female 1.21* 1.12 to 1.32
Male 1.00
Cause of death
Cardiovascular disease 0.75* 0.67 to 0.84
Haematological cancer 1.00 0.77 to 1.29
Neurological condition 1.10 0.97 to 1.26
Respiratory illness 0.75* 0.65 to 0.87
‘Other’ causes‡ 0.72* 0.63 to 0.81
Non-haematological cancers 1.00
Level of deprivation of area of residence (IMD quintile)
Most deprived 0.83* 0.73 to 0.95
Second most deprived 0.90 0.80 to 1.02
Third most deprived 0.98 0.87 to 1.10
Fourth most deprived 1.00 0.89 to 1.12
Least deprived 1.00
Relationship of respondent
Child/friend/other 0.66* 0.60 to 0.73
Spouse or partner 1.00
Ethnicity
Black or Asian minority ethnic 0.77 0.59 to 1.01
White 1.00
Advance care plan§
Yes 2.27* 2.04 to 2.53
No 1.00
Per cent correctly classified
(predicted vs observed)
60.7%
*p Value <0.01.
†Dependent variable: overall care was outstanding or excellent; ‘no’ coded
as 0; ‘yes’ coded as 1.
‡Other than cancer, cardiovascular disease, neurological conditions, renal
failure or respiratory illness.
§Indicated by having expressed a preference for place of death that was
recorded by healthcare staff.
IMD, Index of Multiple Deprivation.
Table 5 Logistic regression of factors associated with sufficient
help and support from health and social services to care for the
decedent at home; N=11 458
Effect OR 99% CI
Age at death
18–64 0.66* 0.55 to 0.80
65–79 0.79* 0.70 to 0.90
80 or above 1.00
Sex
Female 1.32* 1.19 to 1.46
Male 1.00
Cause of death
Cardiovascular disease 0.82* 0.71 to 0.95
Haematological cancer 0.72* 0.53 to 0.97
Neurological condition 0.83 0.68 to 1.02
Respiratory illness 0.84* 0.70 to 1.00
‘Other’ causes‡ 0.78* 0.67 to 0.91
Non-haematological cancers 1.00
Level of deprivation of area of residence (IMD quintile)
Most deprived 0.77* 0.65 to 0.91
Second most deprived 0.80* 0.68 to 0.93
Third most deprived 0.92 0.79 to 1.07
Fourth most deprived 0.93 0.80 to 1.08
Least deprived 1.00
Relationship of respondent
Child/friend/other 0.49* 0.43 to 0.55
Spouse or partner 1.00
Ethnicity
Black or Asian minority ethnic 0.83 0.61 to 1.13
White 1.00
Advance care plan§
Yes 2.02* 1.77 to 2.29
No 1.00
Per cent correctly classified
(predicted vs observed)
62.3%
*p Value <0.01.
†Dependent variable: ‘insufficient support’ coded as 0; ‘sufficient support’
coded as 1.
‡Other than cancer, cardiovascular disease, neurological conditions, renal
failure or respiratory illness.
§Indicated by having expressed a preference for place of death that was
recorded by healthcare staff.
IMD, Index of Multiple Deprivation.
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Table 7 Logistic regression of factors with decedent having their
pain relieved ‘completely, all the time’ while at home, in a care
home and in hospital†
Effect OR 99% CI
Home (n=9019)
Age at death
18–64 0.73* 0.57 to 0.94
65–79 0.89 0.74 to 1.06
80 or above 1.00
Sex
Female 1.09 0.94 to 1.27
Male 1.00
Cause of death
Cardiovascular disease 0.60* 0.48 to 0.76
Haematological cancer 0.72 0.48 to 1.08
Neurological condition 1.20 0.87 to 1.66
Respiratory illness 0.76* 0.58 to 1.00
‘Other’ causes‡ 0.63* 0.49 to 0.80
Non-haematological cancers 1.00
Level of deprivation of area of residence (IMD quintile)
Most deprived 1.13 0.88 to 1.45
Second most deprived 1.02 0.80 to 1.28
Third most deprived 1.08 0.86 to 1.35
Fourth most deprived 1.00 0.80 to 1.25
Least deprived 1.00
Relationship of respondent
Child/friend/other 0.58* 0.49 to 0.69
Spouse or partner 1.00
Ethnicity
Black or Asian minority ethnic 0.80 0.49 to 1.30
White 1.00
Advance care plan§
Yes 2.32* 1.97 to 2.73
No 1.00
Per cent correctly classified
(predicted vs observed)
65.3%
Care home (n=5001)
Age at death
18–64 0.93 0.58 to 1.49
65–79 0.76* 0.60 to 0.97
80 or above 1.00
Sex
Female 1.06 0.90 to 1.24
Male 1.00
Cause of death
Cardiovascular disease 0.93 0.73 to 1.19
Haematological cancer 0.75 0.35 to 1.60
Neurological condition 1.24 0.98 to 1.56
Respiratory illness 1.02 0.76 to 1.39
‘Other’ causes‡ 0.96 0.75 to 1.23
Non-haematological cancers 1.00
Level of deprivation of area of residence (IMD quintile)
Most deprived 1.07 0.83 to 1.38
Second most deprived 1.01 0.80 to 1.28
Continued
Table 7 Continued
Effect OR 99% CI
Third most deprived 1.18 0.94 to 1.48
Fourth most deprived 1.03 0.82 to 1.28
Least deprived 1.00
Relationship of respondent
Child/friend/other 0.64* 0.49 to 0.85
Spouse or partner 1.00
Ethnicity
Black or Asian minority ethnic 0.49 0.22 to 1.08
White 1.00
Advance care plan§
Yes 1.17 0.94 to 1.45
No 1.00
Per cent correctly classified
(predicted vs observed)
54.6%
Hospital (n=10 217)
Age at death
18–64 0.85 0.69 to 1.04
65–79 0.92 0.80 to 1.05
80 or above 1.00
Sex
Female 0.97 0.87 to 1.09
Male 1.00
Cause of death
Cardiovascular disease 1.12 0.96 to 1.31
Haematological cancer 1.10 0.81 to 1.51
Neurological condition 1.43* 1.17 to 1.75
Respiratory illness 1.05 0.86 to 1.29
‘Other’ causes‡ 1.19* 1.01 to 1.40
Non-haematological cancers 1.00
Level of deprivation of area of residence (IMD quintile)
Most deprived 1.20 * 1.00 to 1.44
Second most deprived 1.07 0.90 to 1.27
Third most deprived 1.04 0.88 to 1.23
Fourth most deprived 1.12 0.95 to 1.32
Least deprived 1.00
Relationship of respondent
Child/friend/other 0.78* 0.68 to 0.90
Spouse or partner 1.00
Ethnicity
Black or Asian minority ethnic 0.57* 0.40 to 0.81
White 1.00
Advance care plan§
Yes 0.89 0.77 to 1.04
No 1.00
Per cent correctly classified
(predicted vs observed)
54.0%
*p Value <0.01.
†Dependent variable: overall care was outstanding or excellent; ‘no’ coded
as 0; ‘yes’ coded as 1.
‡Other than cancer, cardiovascular disease, neurological conditions, renal
failure or respiratory illness.
§Indicated by having expressed a preference for place of death that was
recorded by healthcare staff.
IMD, Index of Multiple Deprivation.
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Of these, half (n=6127) felt they had all the help and
support from health and social services they wanted
and 22% (n=2718) cared for someone with a prefer-
ence for place of death recorded by healthcare staff.
Those who cared for someone with a recorded prefer-
ence had significantly greater odds of receiving suffi-
cient support (OR 2.02; 99% CI 1.77 to 2.29).
These, along with being a spouse or partner, were the
most important factors. Other significant factors were
the decedent being aged 80 or over, female and
having other factors with significantly (non-haemato-
logical) cancer or a neurological condition (including
dementia), as well as living in the least deprived areas.
Full results are given in table 5.
Overall quality of care
Forty per cent of respondents (n=9268) thought that
overall quality of care in the last 3 months of life was
‘outstanding’ or ‘excellent’, while 53% (n=12 065)
rated it ‘good’, ‘fair’ or ‘poor’ and 7% gave no
opinion. In cases where an opinion was given, 16%
had a preference for place of death recorded by
healthcare staff, with these decedents having signifi-
cantly greater odds of receiving care considered to be
‘outstanding’ or ‘excellent’ (OR 2.27; 99% CI 2.04 to
2.53). This factor had the largest effect. Other signifi-
cant factors were being over 80 (compared with age
65–79), being female, having a cancer diagnosis
(when compared with having a cardiovascular, respira-
tory or ‘other’ condition, but not having a neuro-
logical condition such as dementia) and living in the
least deprived areas. Table 6 provides full results.
Pain management
Forty-three per cent of the total sample (n=9716) had
pain that required management while being cared for
at home. Eighteen per cent (n=1731) of these had
their pain relieved ‘completely, all the time’ while
82% (n=7985) continued to experience pain to some
degree. The 24% that had a preferred place of death
recorded by healthcare staff had significantly greater
odds of having their pain relieved ‘completely, all the
time’ (OR 2.32; 99% CI 1.97 to 2.73). This analysis
controlled for cause of death, so this effect was inde-
pendent of the symptom burden associated with dif-
ferent conditions. This was the factor with the largest
effect. Other significant factors were being aged 80 or
over (compared with 18–64), having a cancer diagno-
sis (compared with cardiovascular, respiratory and
‘other’ conditions, but not neurological conditions
including dementia) and having a spouse or partner.
Twenty-three per cent of the total sample (n=5374)
had pain that required management while being cared
for in a care home. Forty-six per cent of these
(n=2480) reported that pain was relieved ‘completely,
all the time’, while the remainder continued to experi-
ence pain to some degree. Having a preferred place of
death recorded by healthcare staff was not significantly
associated with this outcome. Only being aged 80 or
over (compared with age 65–79) and having a spouse
or partner were significant factors. Forty-eight per cent
of the total sample (n=10 974) required pain manage-
ment while being cared for in hospital. Of these, 39%
(n=4235) had pain that was relieved ‘completely, all
the time’. The only significant factors were having a
neurological condition (including dementia) or ‘other’
condition, living in the most deprived IMD quintile,
having a spouse or partner and being of white ethni-
city. Full results are set out in table 7.
DISCUSSION
Strengths and limitations
The National Survey of Bereaved People is statistically
well powered. Information on place of death is taken
directly from death certificates and the survey includes
a wide range of demographic indicators, allowing us
to control for covariates. These include factors that
previous studies have shown to be associated with a
greater likelihood of home death, including cancer
diagnosis,9–11 living in a more affluent area9 12 13 and
having a spouse or partner,9 14 and with death in a
care home, including being aged 80 or over.7 9
Nonetheless, we were limited to covariates in the data
set and important explanatory variables may have
been omitted, such as clinical need or functionality,
decedents’ and family members’ attitudes to dying,
and the availability and practices of local services.14 15
We were also not able to take account of when and in
what context preferences were expressed, the extent
and quality of discussion underpinning these or
whether other preferences were expressed and/or met.
How findings compare with previous studies
Despite emphasis in policy, there is little research on
the relationship between advance care planning and
place of death in England, and none, prior to this
study, using nationally representative, individual-level
data. In a systematic review of international research
on the effects of advance care planning,
Brinkman-Stoppelenburg et al16 identified 12 studies
with place of death as an outcome. Five used nationally
representative samples. These included a study based
on a postal survey of a large random sample of general
practices in the UK, which found that practices using
advance care planning were 2.5 times more likely to
have a home death rate for patients with cancer of over
60%.17 The remaining four studies involved secondary
analysis of data from the US Health and Retirement
Study (HRS).18–21 Two found an association between
reduced risk of hospital death and having an advance
directive18 or a treatment-limiting advance directive.19
Since the review by Brinkman-Stoppelenburg et al,
two further HRS-based studies have found a positive
association. Bischoff et al22 found a lower risk of hos-
pital death for those who had either completed an
advance directive, had an end of life care discussion
with a family member or had assigned power of
Research
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attorney, while Nicholas et al23 found a lower risk of
hospital death for people with a treatment-limiting
advance directive, among those with severe dementia
living in the community and those with normal cogni-
tion living in care homes.
Effect sizes in our study were greater than in these
HRS-based studies. The difference in the predicted
probability of hospital death between those with and
without an advance care plan for three of the studies
were 9.8%,19 −13%18 and −17.9%,23 and in the
remaining study, the relative risk of hospital death for
those with an advance care plan was 0.87.22 By com-
parison, in our study, the difference in the predicted
probability of hospital death was −21%, and the rela-
tive risk of dying in hospital with an advance care
plan was 0.46.
It is difficult to know how to interpret these differ-
ences because of the different data sources and mea-
sures used. While the National Survey of Bereaved
People and HRS have different designs, both are large
scale and nationally representative and both gather data
from relatives. The National Survey of Bereaved People
collects data for decedents of all ages, while HRS
includes only people aged 50 and over. However, in the
National Survey of Bereaved People, only 5% are aged
under 60 (table 1). It could be that the larger effect sizes
in our study reflect that the indicator of advance care
planning used is specific to the primary outcome (ie,
place of death). It also includes only preferences that
are recorded by healthcare staff, which are therefore
more likely to be acted on. In comparison, advance
directives, the main indicator used in the HRS studies,
can include preferred place of death, although this will
not always be the case. Nonetheless, the vast majority
will be used to limit medical treatments requiring hospi-
talisation in the last weeks and days of life. Preferences
should also be recorded by healthcare staff since
Medicare-registered and Medicaid-registered health-
care providers are required, under the PSDA (1990), to
record advance directives in medical records.
The larger effect sizes may also, therefore, reflect
substantive differences between England and the USA.
We know from previous research that levels of
advance care planning are higher in the USA than in
the UK,24 25 with evidence that some advance care
planning in the USA is ‘document-led’ or ‘tick-box’,
and therefore potentially less effective.26–28 In
England, an expressed preference for death in usual
place of residence may be, at least where recorded by
healthcare staff, more considered and appropriate to
the needs and circumstances of patients and their fam-
ilies. Advance care planning and/or the recording of
end of life care preferences by healthcare staff may
also be undertaken more selectively, focusing on those
who are most able to be supported to die in their
usual place of residence. Results from our study indi-
cate that having a recorded preference for place of
death is also associated with enhanced support to be
cared for and die at home and a better experience of
care. There could be various reasons for this. It may
be that additional support is provided to these patients
to help them achieve a home death. Alternatively,
family members may give a better evaluation of the
care received when, in fact, these patients are simply
more readily supported to be cared for and die at
home. It could also be the case that health and care
systems that promote advance care planning tend to be
those with higher quality community-based services.
Implications for policy and future research
Our study establishes for the first time, using nation-
ally representative, individual-level data, that there is
an association, in England, between advance care
planning, using the indicator of an expressed prefer-
ence for place of death recorded by healthcare staff,
and a greater likelihood of dying in one’s usual place
of residence. These findings provide broad support
for the emphasis on advance care planning in end of
life care policy in England and, in particular, for the
role of advance care planning in helping to shift care
and resources for end of life care away from hospitals
and towards alternative community-based provision.
Having a recorded preference for place of death was
also found to be associated with a range of quality
outcomes. However, the mechanisms underlying these
relationships are not well understood. It is unclear, for
example, why some people engage (or are engaged) in
advance care planning and/or have their preferences
for place of death recorded by healthcare staff while
others do not, and how and when this occurs. We also
need to better understand how advance care planning
is linked to wider service responses, including the pro-
vision of necessary support to help people to die in
their usual place of residence. The larger effect sizes
found in our study compared with similar research in
the USA may also reflect important differences
between England and the USA in how advance care
planning is undertaken, when and how preferences
are recorded by healthcare staff and the ways in which
health and social care services respond. Research into
these underlying processes will help in developing and
refining advance care planning practices and, given
the practical and ethical challenges of randomised
designs in this area, help researchers design better
controlled observational studies into the effects of
advance care planning in future.29 30
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